Shilei Wang
Impact in
- Animal Science and Zoology top 5%
- Animal Virus Infections Studies
- Pharmaceutical Science top 5%
Papers in
- Epidemiology 18
- Influenza Virus Research Studies 8
- Respiratory viral infections research 4
Shilei Wang
70 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 138
- Animal Science and Zoology 178
- Pharmaceutical Science 70
- Developmental Neuroscience 40
- Infectious Diseases 157
- Epidemiology 272
Countries citing papers authored by Shilei Wang
This map shows the geographic impact of Shilei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Wang more than expected).
Fields of papers citing papers by Shilei Wang
This network shows the impact of papers produced by Shilei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Wang. The network helps show where Shilei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shilei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 57 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 25 | |
| 12 | 2021 | 24 | |
| 13 | 2021 | 7 | |
| 14 | The Cytotoxic Molecule Ansamitocin P-3 Suppresses Cell Proliferation and Tumor Growth in Lung Carcinoma | 2021 | 1 |
| 15 | 2021 | 3 | |
| 16 | 2020 | 19 | |
| 17 | 2019 | 1 | |
| 18 | 2018 | 10 | |
| 19 | 2016 | 11 | |
| 20 | 2012 | 4 |
About Shilei Wang
Shilei Wang is a scholar working on Epidemiology, Pharmaceutical Science, Biological Psychiatry, Animal Science and Zoology and Critical Care and Intensive Care Medicine, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (8 papers), 2D Materials and Applications (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), MXene and MAX Phase Materials (4 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Animal Virus Infections Studies (4 papers), Bone Tissue Engineering Materials (4 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Animal Science and Zoology (178 citations), Pharmaceutical Science (70 citations), Developmental Neuroscience (40 citations), Infectious Diseases (157 citations) and Epidemiology (272 citations). Shilei Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Shuo Su, Gang Xing, Jianguo Wang, Jiyong Zhou, Gairu Li, Guan‐Zhu Han, Michael Veit, Henan Zhu, Cui Huang and Wanting He. Their work appears in journals such as Artificial Organs, Habitat International, Human Vaccines & Immunotherapeutics, Drug Delivery and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.